Open Lab as a source of hits and leads against tuberculosis, malaria and kinetoplastid diseases

Lluís Ballell; Mike Strange; Nicholas Cammack; Alan H. Fairlamb; Leszek Borysiewicz

doi:10.1038/nrd.2016.51

Open Lab as a source of hits and leads against tuberculosis, malaria and kinetoplastid diseases

Lluís Ballell (Lead / Corresponding author), Mike Strange, Nicholas Cammack, Alan H. Fairlamb, Leszek Borysiewicz

Biological Chemistry and Drug Discovery

Research output: Contribution to journal › Letter › peer-review

9 Citations (Scopus)

Original language	English
Article number	292
Number of pages	3
Journal	Nature Reviews Drug Discovery
Volume	15
Issue number	4
Early online date	29 Mar 2016
DOIs	https://doi.org/10.1038/nrd.2016.51
Publication status	Published - Apr 2016

Keywords

Animals
Developing countries
Drug discovery
Foundations
Humans
Malaria
Neglected diseases
Tuberculosis
Comment
Letter

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/nrd.2016.51

Cite this

@article{53804891768946669c796bab85a870a7,

title = "Open Lab as a source of hits and leads against tuberculosis, malaria and kinetoplastid diseases",

keywords = "Animals, Developing countries, Drug discovery, Foundations, Humans, Malaria, Neglected diseases, Tuberculosis, Comment, Letter",

author = "Llu{\'i}s Ballell and Mike Strange and Nicholas Cammack and Fairlamb, {Alan H.} and Leszek Borysiewicz",

year = "2016",

month = apr,

doi = "10.1038/nrd.2016.51",

language = "English",

volume = "15",

journal = "Nature Reviews Drug Discovery",

issn = "1474-1776",

publisher = "Nature Research",

number = "4",

}

TY - JOUR

T1 - Open Lab as a source of hits and leads against tuberculosis, malaria and kinetoplastid diseases

AU - Ballell, Lluís

AU - Strange, Mike

AU - Cammack, Nicholas

AU - Fairlamb, Alan H.

AU - Borysiewicz, Leszek

PY - 2016/4

Y1 - 2016/4

KW - Animals

KW - Developing countries

KW - Drug discovery

KW - Foundations

KW - Humans

KW - Malaria

KW - Neglected diseases

KW - Tuberculosis

KW - Comment

KW - Letter

U2 - 10.1038/nrd.2016.51

DO - 10.1038/nrd.2016.51

M3 - Letter

C2 - 27020099

SN - 1474-1776

VL - 15

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

IS - 4

M1 - 292

ER -